AllianceBernstein’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-109,538
| Closed | -$174K | – | 3350 |
|
|
2025
Q1 | $174K | Hold |
109,538
| – | – | ﹤0.01% | 2962 |
|
|
2024
Q4 | $332K | Hold |
109,538
| – | – | ﹤0.01% | 2817 |
|
|
2024
Q3 | $403K | Sell |
109,538
-1,200
| -1% | -$4.42K | ﹤0.01% | 2772 |
|
|
2024
Q2 | $453K | Buy |
110,738
+53,020
| +92% | +$217K | ﹤0.01% | 2722 |
|
|
2024
Q1 | $910K | Hold |
57,718
| – | – | ﹤0.01% | 2318 |
|
|
2023
Q4 | $874K | Hold |
57,718
| – | – | ﹤0.01% | 2341 |
|
|
2023
Q3 | $1.16M | Sell |
57,718
-1,263,717
| -96% | -$25.4M | ﹤0.01% | 2153 |
|
|
2023
Q2 | $37.3M | Buy |
1,321,435
+31,139
| +2% | +$878K | 0.02% | 662 |
|
|
2023
Q1 | $22.2M | Sell |
1,290,296
-75,202
| -6% | -$1.29M | 0.01% | 801 |
|
|
2022
Q4 | $27.5M | Buy |
1,365,498
+33,614
| +3% | +$677K | 0.01% | 747 |
|
|
2022
Q3 | $28.8M | Sell |
1,331,884
-22,579
| -2% | -$489K | 0.01% | 724 |
|
|
2022
Q2 | $38.1M | Buy |
1,354,463
+357,704
| +36% | +$10.1M | 0.02% | 652 |
|
|
2022
Q1 | $46M | Buy |
996,759
+69,822
| +8% | +$3.22M | 0.02% | 620 |
|
|
2021
Q4 | $77.9M | Sell |
926,937
-59,016
| -6% | -$4.96M | 0.03% | 503 |
|
|
2021
Q3 | $65.7M | Buy |
985,953
+45,125
| +5% | +$3.01M | 0.03% | 538 |
|
|
2021
Q2 | $50.1M | Sell |
940,828
-164,454
| -15% | -$8.75M | 0.02% | 621 |
|
|
2021
Q1 | $48M | Buy |
1,105,282
+270,834
| +32% | +$11.8M | 0.02% | 619 |
|
|
2020
Q4 | $43.3M | Buy |
834,448
+63,678
| +8% | +$3.31M | 0.02% | 621 |
|
|
2020
Q3 | $25.2M | Buy |
770,770
+272,498
| +55% | +$8.91M | 0.01% | 734 |
|
|
2020
Q2 | $23.9M | Buy |
+498,272
| New | +$23.9M | 0.01% | 709 |
|